Relationship between peak expiratory flow and incidence of frailty, deaths and falls among nursing home residents: Results of the SENIOR cohort.


Journal

Archives of gerontology and geriatrics
ISSN: 1872-6976
Titre abrégé: Arch Gerontol Geriatr
Pays: Netherlands
ID NLM: 8214379

Informations de publication

Date de publication:
Historique:
received: 07 01 2019
revised: 01 07 2019
accepted: 11 07 2019
pubmed: 30 7 2019
medline: 22 4 2020
entrez: 30 7 2019
Statut: ppublish

Résumé

To correlate peak expiratory flow (PEF) with the incidence of frailty, deaths and falls among nursing home residents. This is a 1-year longitudinal analysis performed on the clinical data of the SENIOR cohort. PEF, measured by peak flow meter, was considered as "low" when the observed value was ≤80% of the theoretical value. Physical capacity was evaluated using Short Physical Performance Battery, balance and gait using Tinetti test and muscle strength using a dynamometer. The incidence of frailty was defined as the transition from a "robust" or "prefrail" status to a "frail" status following Fried's criteria. Deaths and falls were also collected. Among 646 subjects included at baseline (83.2 ± 9 years and 72.1% women), 297 (45.7%) displayed a low PEF. In this subgroup, physical capacity (p-values from 0.01 to <0.001), muscle strength (p < 0.001), balance and gait score (p < 0.001) were significantly lower compared to subjects displaying normal PEF. Subjects who became frail after one year displayed a lower % of the theoretical PEF value compared to those that did not (88.52 ± 45.06 vs 102.78 ± 50.29, respectively, p = 0.03). After adjustment for potential confounding variables (calf circumference, Tinetti test, SPPB test and handgrip strength), PEF was no longer associated with the occurrence of frailty. There was no association between PEF and mortality and falls. In a nursing home setting, PEF is not an independent factor associated with the incidence of frailty, deaths and falls.

Identifiants

pubmed: 31357107
pii: S0167-4943(19)30156-6
doi: 10.1016/j.archger.2019.103913
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103913

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Alexia Charles (A)

Department of Public Health, Epidemiology and Health Economics, University of Liège, WHO Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing, Avenue Hippocrate 13, Liège, Belgium. Electronic address: alexia.charles@uliege.be.

Fanny Buckinx (F)

Department of Public Health, Epidemiology and Health Economics, University of Liège, WHO Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing, Avenue Hippocrate 13, Liège, Belgium. Electronic address: fanny.buckinx@uliege.be.

Didier Cataldo (D)

Department of Respiratory Diseases and Laboratory of Tumor Biology and Development, University of Liège and CHU Liege, Avenue de l'Hôpital 11, Liège, Belgium. Electronic address: didier.cataldo@uliege.be.

Xavier Rygaert (X)

Department of Public Health, Epidemiology and Health Economics, University of Liège, WHO Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing, Avenue Hippocrate 13, Liège, Belgium. Electronic address: xavier.rygaert@hotmail.com.

Bastien Gruslin (B)

Department of Public Health, Epidemiology and Health Economics, University of Liège, WHO Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing, Avenue Hippocrate 13, Liège, Belgium. Electronic address: bastien.gruslin@student.uliege.be.

Jean-Yves Reginster (JY)

Department of Public Health, Epidemiology and Health Economics, University of Liège, WHO Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing, Avenue Hippocrate 13, Liège, Belgium; Chair for Biomarkers of Osteoporosis, Biochemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia. Electronic address: jyreginster@uliege.be.

Olivier Bruyère (O)

Department of Public Health, Epidemiology and Health Economics, University of Liège, WHO Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing, Avenue Hippocrate 13, Liège, Belgium; Department of Rehabilitation and Sport Sciences, University of Liège, Allée des Sports 4, Liège, Belgium. Electronic address: olivier.bruyere@uliege.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH